Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,981,508
+$8,327,700 QoQ
Shares Held
71,090
+156.3% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#146
of 768 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Horizon Investments, LLC holds $36,074,962 across 11 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (33.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
23,364 | $12,659,316 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
71,090 | $11,981,508 | |
| 3 | HLN |
Haleon plc
|
274,831 | $2,564,173 | |
| 4 | VTRS |
Viatris Inc
|
125,321 | $1,990,097 | |
| 5 | ZTS |
Zoetis Inc.
|
24,833 | $1,784,499 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
45,561 | $1,543,606 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
25,390 | $1,041,751 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
9,779 | $809,505 |
All Filings in NBIX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,981,508 | 71,090 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,653,808 | 27,735 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,813,414 | 55,090 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $5,420,914 | 38,616 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,220,826 | 9,713 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $1,843 | 16 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,376 | 10 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,379 | 10 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $527 | 4 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||